首页> 外文期刊>Retina >Choroidal granulomas in systemic sarcoidosis.
【24h】

Choroidal granulomas in systemic sarcoidosis.

机译:全身结节病中的脉络膜肉芽肿。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the clinical course, including response to therapy, of patients with macular and peripapillary choroidal granulomas secondary to systemic sarcoidosis. METHODS: This is a retrospective case study and literature review. Nine patients with choroidal granulomas were identified. Eight patients had a tissue biopsy confirming sarcoidosis; one was diagnosed from clinical history and typical gallium scan. Ocular examinations included fundus examination, fluorescein angiography, and visual field examination. Eight patients had magnetic resonance imaging (MRI) scans looking for intracranial granulomas. Treatment consisted of oral prednisone in eight patients (one with concomitant subconjunctival triamcinolone); one patient received no treatment because of good vision and granuloma in the nasal retina. Variables studied included visual acuity (VA), response of granulomas to treatment, time to recurrence, and associated anterior segment findings. RESULTS: Eight of nine patients had a solitary lesion whereas one had multifocal involvement. The granulomas ranged in size from one half to four disk diameters. Eight patients had blurry vision; one was asymptomatic. All nine patients had hilar adenopathy and/or pulmonary parenchymal disease. No patient had nonocular neurologic symptoms and in eight patients who underwent MRI examination no intracranial granulomas were detected. Of the eyes that were treated (n = 8) all had decrease in the size of the choroidal mass at an average of 4 months of treatment. Two had complete resolution. Mean follow-up was 29.2 months. At the time of initial diagnosis only one patient had an active anterior uveitis. Five of nine patients had at least one recurrence. Mean time to recurrence was 7.6 months after discontinuing oral prednisone. The VA at presentation ranged from 20/30 to 20/300. Final VA was 20/30 or better in all patients. CONCLUSIONS: Choroidal granulomas related to systemic sarcoidosis respond well to oral corticosteroids. They may recur but good vision can be maintained. They are not typically associated with concomitant iritis and also do not appear to be associated with intracranial granulomas.
机译:目的:评估系统性结节病继发的黄斑和乳头状脉络膜肉芽肿的临床病程,包括对治疗的反应。方法:这是一项回顾性案例研究和文献综述。确定了9例脉络膜肉芽肿患者。 8例患者经组织活检证实结节病。根据临床病史和典型的镓扫描诊断出一种。眼科检查包括眼底检查,荧光素血管造影和视野检查。八名患者进行了磁共振成像(MRI)扫描,以寻找颅内肉芽肿。八名患者接受口服泼尼松治疗(一名伴结膜下曲安奈德治疗);一名患者由于视力良好和鼻视网膜肉芽肿而未接受任何治疗。研究的变量包括视敏度(VA),肉芽肿对治疗的反应,复发时间以及相关的前节发现。结果:9例患者中有8例患有孤立病变,而1例患有多灶性病变。肉芽肿的大小范围从直径的一半到四个。 8例患者视力模糊;一个是无症状的。所有九名患者均患有肺门腺病和/或肺实质疾病。没有患者有非眼神经症状,在接受MRI检查的八名患者中未发现颅内肉芽肿。平均治疗4个月,经过治疗的眼睛(n = 8)的脉络膜块大小均减小。两个有完整的解决方案。平均随访29.2个月。在初步诊断时,只有一名患者患有活动性前葡萄膜炎。 9名患者中有5名至少复发1次。平均复发时间为停药口服泼尼松后7.6个月。演讲时的视场范围从20/30到20/300。所有患者的最终VA为20/30或更高。结论:与全身结节病相关的脉络膜肉芽肿对口服皮质类固醇激素反应良好。他们可能会复发,但可以维持良好的视力。它们通常不伴有虹膜炎,也似乎不伴有颅内肉芽肿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号